Gathering data to use it to improve care delivery is easier said than done, explained Charles Saunders, MD, CEO of Integra Connect.
Gathering data to use it to improve care delivery is easier said than done, explained Charles Saunders, MD, CEO of Integra Connect.
Transcript
Technology has led to greater data collection: how can practices ensure they are gathering data and using it in a meaningful way?
Well, the first part is gathering it. And that’s not as easy as it might seem. It’s not just a matter of reporting measures out of the electronic health record (EHR). In many cases, measures that are important—either for calculating quality measures or MIPS [Merit-based Incentive Payment System] measures—may not even be in the electronic health record in a structured format. So, they need to be somehow captured, either through natural language processing or through manual data abstraction. So, the data curation part of it can be very tricky.
In addition to that, if they have holistic responsibilities for patients with the Oncology Care Model, they also need to have claims. They need to integrate claims from CMS and understand those claims and link those to the clinical information from the EHR and other sources of pharmacy, lab, etc. And that requires integrative technology.
How is technology being used to identify inefficiencies?
Well, one of the most useful things that can be done is to take the CMS claims and to identify cost and utilization of services. So, that means acute care days, SNF [skilled nursing facility] days, avoidable emergency department visits, as well as hospice use and other high-cost, high-tech services, and specialty drugs. And the use of those and the units of service can be determined from the CMS claims data and compared against benchmarks to determine whether or not there are savings opportunities, and whether they’re efficient and not efficient and the use of those services.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen